Camlin Fine Sciences is currently trading at Rs. 99.30, up by 6.90 points or 7.47% from its previous closing of Rs. 92.40 on the BSE.
The scrip opened at Rs. 92.90 and has touched a high and low of Rs. 99.40 and Rs. 92.75 respectively. So far 190826 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 118.90 on 06-Jan-2017 and a 52 week low of Rs. 71.00 on 13-Sep-2017.
Last one week high and low of the scrip stood at Rs. 99.40 and Rs. 90.00 respectively. The current market cap of the company is Rs. 982.83 crore.
The promoters holding in the company stood at 40.88%, while institutions and non-institutions held 9.26% and 49.86% respectively.
Camlin Fine Sciences has received an approval to issue and allot 1,72,41,379 Equity Shares of face value Re 1 each to eligible qualified institutional buyers at the issue price of Rs 87 per Equity Share, aggregating to Rs 150 crore. The Security Issue and QIP Committee of the Company at its meeting held on November 23, 2017, approved the same.
Camlin Fine Sciences is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).